NM_001330360.2:c.109C>T
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2
The NM_001330360.2(POLA1):c.109C>T(p.Arg37Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000153 in 1,177,478 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 7 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330360.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000181 AC: 2AN: 110592Hom.: 0 Cov.: 22 AF XY: 0.0000608 AC XY: 2AN XY: 32906
GnomAD3 exomes AF: 0.0000256 AC: 4AN: 156056Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 46654
GnomAD4 exome AF: 0.0000150 AC: 16AN: 1066886Hom.: 0 Cov.: 25 AF XY: 0.0000148 AC XY: 5AN XY: 338390
GnomAD4 genome AF: 0.0000181 AC: 2AN: 110592Hom.: 0 Cov.: 22 AF XY: 0.0000608 AC XY: 2AN XY: 32906
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 31 of the POLA1 protein (p.Arg31Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of POLA1-related conditions (PMID: 30392784). ClinVar contains an entry for this variant (Variation ID: 2169638). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt POLA1 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at